91 |
|
Contests with investment
|
Munster, J.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
92 |
|
Why do firms both make and buy? An investigation of concurrent sourcing
|
Parmigiani, A.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
93 |
|
Strategic schemas, strategic flexibility, and firm performance: the moderating role of industry clockspeed
|
Nadkarni, S.; Narayanan, V. K.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
94 |
|
The cost of US pharmaceutical price regulation: a financial simulation model of R&D decisions
|
Abbott, T. A.; Vernon, J. A.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
95 |
|
Uncertainty and choice: the challenges of pharmaceutical efficacy, safety, and cost
|
Scherer, F. M.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
96 |
|
`Branded Generics' as a strategy to limit cannibalization of pharmaceutical markets
|
Reiffen, D.; Ward, M. R.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
97 |
|
Why do prices rise faster than they fall? With an application to mortgage rates
|
Toolsema, L. A.; Jacobs, J. P.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
98 |
|
Thick markets, market competition and pricing dynamics: evidence from retailers
|
Axarloglou, K.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
99 |
|
Corporate investments and growth options
|
Reuer, J. J.; Tong, T. W.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
100 |
|
Reply to `the paradox of inelastic sports pricing'
|
Fort, R.
|
John Wiley & Sons, Ltd
|
2007
|
|
|